Amgen is already a leader in this very large therapeutic category with Enbrel®(etanercept), a biologic medicine marketed byAmgen in the U.S. andCanada to treat several chronic inflammatory diseases, including moderate-to-sever...
dermatologist and clinical investigator at SKiN Centre for Dermatology and assistant professor, Queen's University,Ontario, Canada. "The study presented at AAD highlighted significant improvement in disease severity, symptoms such as itch, pain, discomfort, and patient-reported quality of ...